These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 8994519)
1. Eicosanoid mediator expression in mononuclear and polymorphonuclear cells in normal subjects and patients with atopic asthma and cystic fibrosis. Kuitert LM; Newton R; Barnes NC; Adcock IM; Barnes PJ Thorax; 1996 Dec; 51(12):1223-8. PubMed ID: 8994519 [TBL] [Abstract][Full Text] [Related]
2. Effects of glucocorticoids on endogenous and transcellular metabolism of eicosanoids in asthma. Vachier I; Chavis C; Majori M; Farce M; Bousquet J; Godard P; Chanez P J Allergy Clin Immunol; 2001 May; 107(5):824-31. PubMed ID: 11344349 [TBL] [Abstract][Full Text] [Related]
3. In situ amplification of 5-lipoxygenase and 5-lipoxygenase-activating protein in allergic airway inflammation and inhibition by leukotriene blockade. Chu SJ; Tang LO; Watney E; Chi EY; Henderson WR J Immunol; 2000 Oct; 165(8):4640-8. PubMed ID: 11035107 [TBL] [Abstract][Full Text] [Related]
4. Differential regulation of cyclo-oxygenase-2 and 5-lipoxygenase-activating protein (FLAP) expression by glucocorticoids in monocytic cells. Goppelt-Struebe M; Schaefer D; Habenicht AJ Br J Pharmacol; 1997 Oct; 122(4):619-24. PubMed ID: 9375956 [TBL] [Abstract][Full Text] [Related]
5. The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating protein. Maxis K; Delalandre A; Martel-Pelletier J; Pelletier JP; Duval N; Lajeunesse D Arthritis Res Ther; 2006; 8(6):R181. PubMed ID: 17156456 [TBL] [Abstract][Full Text] [Related]
7. Increases in 5-lipoxygenase activating protein expression account for enhanced capacity for 5-lipoxygenase metabolism that accompanies differentiation of peripheral blood monocytes into alveolar macrophages. Coffey MJ; Wilcoxen SE; Peters-Golden M Am J Respir Cell Mol Biol; 1994 Aug; 11(2):153-8. PubMed ID: 8049076 [TBL] [Abstract][Full Text] [Related]
8. Leukotriene and prostanoid pathway enzymes in bronchial biopsies of seasonal allergic asthmatics. Seymour ML; Rak S; Aberg D; Riise GC; Penrose JF; Kanaoka Y; Austen KF; Holgate ST; Sampson AP Am J Respir Crit Care Med; 2001 Dec; 164(11):2051-6. PubMed ID: 11739134 [TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase and lipoxygenase enzymes in sinonasal mucosa of patients with cystic fibrosis. Owens JM; Shroyer KR; Kingdom TT Arch Otolaryngol Head Neck Surg; 2008 Aug; 134(8):825-31. PubMed ID: 18711055 [TBL] [Abstract][Full Text] [Related]
10. Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma. Adamjee J; Suh YJ; Park HS; Choi JH; Penrose JF; Lam BK; Austen KF; Cazaly AM; Wilson SJ; Sampson AP J Pathol; 2006 Jul; 209(3):392-9. PubMed ID: 16583357 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis. Pérez-Novo CA; Watelet JB; Claeys C; Van Cauwenberge P; Bachert C J Allergy Clin Immunol; 2005 Jun; 115(6):1189-96. PubMed ID: 15940133 [TBL] [Abstract][Full Text] [Related]
12. Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. Albert D; Zündorf I; Dingermann T; Müller WE; Steinhilber D; Werz O Biochem Pharmacol; 2002 Dec; 64(12):1767-75. PubMed ID: 12445866 [TBL] [Abstract][Full Text] [Related]
13. 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. Woods JW; Evans JF; Ethier D; Scott S; Vickers PJ; Hearn L; Heibein JA; Charleson S; Singer II J Exp Med; 1993 Dec; 178(6):1935-46. PubMed ID: 8245774 [TBL] [Abstract][Full Text] [Related]
14. Expression of 5-lipoxygenase and 5-lipoxygenase-activating protein mRNAs in the peripheral blood leukocytes of asthmatics. Koshino T; Takano S; Houjo T; Sano Y; Kudo K; Kihara H; Kitani S; Takaishi T; Hirai K; Ito K; Morita Y Biochem Biophys Res Commun; 1998 Jun; 247(2):510-3. PubMed ID: 9642160 [TBL] [Abstract][Full Text] [Related]
15. BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly. Garscha U; Voelker S; Pace S; Gerstmeier J; Emini B; Liening S; Rossi A; Weinigel C; Rummler S; Schubert US; Scriba GK; Çelikoğlu E; Çalışkan B; Banoglu E; Sautebin L; Werz O Biochem Pharmacol; 2016 Nov; 119():17-26. PubMed ID: 27592027 [TBL] [Abstract][Full Text] [Related]
16. Differential effects of cell density on 5-lipoxygenase (5-LO), five-lipoxygenase-activating protein (FLAP) and interleukin-1 beta (IL-1 beta) expression in human neutrophils. Jobin C; Gauthier J Inflammation; 1997 Apr; 21(2):235-50. PubMed ID: 9187965 [TBL] [Abstract][Full Text] [Related]
17. Enzymes involved in the conversion of arachidonic acid to eicosanoids in the skin of atopic dogs. Schlotter YM; Riemers FM; Rutten VP; Knol EF; Willemse T Exp Dermatol; 2010 Aug; 19(8):e317-9. PubMed ID: 20201960 [TBL] [Abstract][Full Text] [Related]
18. Are there attacking points in the eicosanoid cascade for chemotherapeutic options in benign meningiomas? Pfister C; Ritz R; Pfrommer H; Bornemann A; Tatagiba MS; Roser F Neurosurg Focus; 2007; 23(4):E8. PubMed ID: 17961045 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the interaction of human 5-lipoxygenase with its activating protein FLAP. Häfner AK; Gerstmeier J; Hörnig M; George S; Ball AK; Schröder M; Garscha U; Werz O; Steinhilber D Biochim Biophys Acta; 2015 Nov; 1851(11):1465-72. PubMed ID: 26327594 [TBL] [Abstract][Full Text] [Related]
20. Human bronchial epithelial cells express an active and inducible biosynthetic pathway for leukotrienes B4 and C4. Jame AJ; Lackie PM; Cazaly AM; Sayers I; Penrose JF; Holgate ST; Sampson AP Clin Exp Allergy; 2007 Jun; 37(6):880-92. PubMed ID: 17517102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]